A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy

Clinical trial NCT00150709 · COMPLETED

Trial details

NCT number: NCT00150709
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Epilepsy, Partial

Start date: 1998-01-26
Primary completion: 2006-01-25
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.